DK0739205T3 - Anvendelse af N-alkylderivater af 1,5-didesoxy-1,5-imino-D-glucitol til behandling af hepatitis-B-virusinfektioner - Google Patents

Anvendelse af N-alkylderivater af 1,5-didesoxy-1,5-imino-D-glucitol til behandling af hepatitis-B-virusinfektioner

Info

Publication number
DK0739205T3
DK0739205T3 DK95905416T DK95905416T DK0739205T3 DK 0739205 T3 DK0739205 T3 DK 0739205T3 DK 95905416 T DK95905416 T DK 95905416T DK 95905416 T DK95905416 T DK 95905416T DK 0739205 T3 DK0739205 T3 DK 0739205T3
Authority
DK
Denmark
Prior art keywords
glucitol
imino
hepatitis
treatment
pct
Prior art date
Application number
DK95905416T
Other languages
English (en)
Inventor
Timothy M Block
Baruch S Blumberg
Raymond A Dwek
Original Assignee
Searle & Co
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co, Monsanto Co filed Critical Searle & Co
Application granted granted Critical
Publication of DK0739205T3 publication Critical patent/DK0739205T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK95905416T 1994-01-13 1994-12-23 Anvendelse af N-alkylderivater af 1,5-didesoxy-1,5-imino-D-glucitol til behandling af hepatitis-B-virusinfektioner DK0739205T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18151994A 1994-01-13 1994-01-13
PCT/US1994/014548 WO1995019172A1 (en) 1994-01-13 1994-12-23 Use of n-alkyl derivatives of 1,5-dideoxy-1,5-imino-d-glucitol for the treatment of hepatitis b virus infections

Publications (1)

Publication Number Publication Date
DK0739205T3 true DK0739205T3 (da) 2000-05-01

Family

ID=22664619

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95905416T DK0739205T3 (da) 1994-01-13 1994-12-23 Anvendelse af N-alkylderivater af 1,5-didesoxy-1,5-imino-D-glucitol til behandling af hepatitis-B-virusinfektioner

Country Status (14)

Country Link
US (1) US6037351A (da)
EP (1) EP0739205B1 (da)
JP (1) JP3628021B2 (da)
KR (1) KR100348657B1 (da)
CN (1) CN1074921C (da)
AT (1) ATE186836T1 (da)
AU (1) AU1403795A (da)
CA (1) CA2181033C (da)
DE (1) DE69421828T2 (da)
DK (1) DK0739205T3 (da)
ES (1) ES2140652T3 (da)
GR (1) GR3032527T3 (da)
PT (1) PT739205E (da)
WO (1) WO1995019172A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100532A1 (en) * 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
DK1030839T3 (da) 1997-11-10 2004-05-03 Searle & Co Anvendelse af alkylerede iminosukkere til behandling af multidrugresistens
US6809083B1 (en) * 1998-02-12 2004-10-26 Richard A. Mueller Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
EP1714676A3 (en) * 1998-02-12 2006-11-15 G.D. Searle LLC. Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
US6274597B1 (en) 1998-06-01 2001-08-14 Mount Sinai School Of Medicine Of New York University Method of enhancing lysosomal α-Galactosidase A
ATE402701T1 (de) * 1999-02-12 2008-08-15 United Therapeutics Corp N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
JP2003505501A (ja) 1999-02-12 2003-02-12 ジー・ディー・サール・アンド・カンパニー 肝炎ウィルス感染の処置のためのグルカミン化合物
EP1658846B1 (en) * 1999-02-12 2008-07-30 United Therapeutics Corporation N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol for treating hepatitis virus infections
ES2302697T3 (es) 1999-08-10 2008-08-01 The Chancellor, Masters And Scholars Of The University Of Oxford Compuestos n-alquilicos de cadena larga y derivados oxa de los mismos y uso como composiciones antivirales.
EP1261339A1 (en) * 2000-02-14 2002-12-04 Pharmacia Corporation Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
WO2006085141A2 (en) * 2004-08-13 2006-08-17 Migenix Inc. Compositions and methods for treating or preventing hepadnaviridae infection
US8975280B2 (en) 2006-05-24 2015-03-10 The Chancellor, Masters And Scholars Of The University Of Oxford Deoxynojirimycin and D-arabinitol analogs and methods of using
JP2010510171A (ja) * 2006-08-21 2010-04-02 ユナイテッド セラピューティクス コーポレーション ウイルス感染症の治療のための併用療法
US8097728B2 (en) 2007-04-30 2012-01-17 Philadelphia Health & Education Corporation Iminosugar compounds with antiflavirus activity
JP2013233113A (ja) * 2012-05-09 2013-11-21 Osaka Univ 物理的負荷への耐性が向上した細胞の製造方法
RU2743694C1 (ru) * 2019-12-04 2021-02-24 Общество с ограниченной ответственностью "29 февраля" Миглустат N-бутил-1,5-дидезокси-1,5-имино-D-глюцит

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
US4849430A (en) * 1988-03-09 1989-07-18 Monsanto Company Method of inhibiting virus
US4957926A (en) * 1988-12-22 1990-09-18 Monsanto Company Method of treating herpesviruses
US5030638A (en) * 1990-02-26 1991-07-09 G. D. Searle & Co. Method of antiviral enhancement

Also Published As

Publication number Publication date
CN1074921C (zh) 2001-11-21
JP3628021B2 (ja) 2005-03-09
EP0739205B1 (en) 1999-11-24
KR100348657B1 (ko) 2003-08-02
EP0739205A1 (en) 1996-10-30
CA2181033A1 (en) 1995-07-20
ES2140652T3 (es) 2000-03-01
WO1995019172A1 (en) 1995-07-20
AU1403795A (en) 1995-08-01
US6037351A (en) 2000-03-14
GR3032527T3 (en) 2000-05-31
CN1149253A (zh) 1997-05-07
JPH09508111A (ja) 1997-08-19
CA2181033C (en) 2007-09-04
DE69421828T2 (de) 2000-04-20
DE69421828D1 (de) 1999-12-30
ATE186836T1 (de) 1999-12-15
PT739205E (pt) 2000-04-28

Similar Documents

Publication Publication Date Title
ATE186836T1 (de) Verwendung von 1,5-dideoxy-1,5-imino-d-glucitol n-alkylderivaten zur behandlung von hepatitis b infektionen
NO20073151L (no) Fremgangsmater og sammensetninger for a behandle hepatitt C virus
BR0110023A (pt) Derivados de nucleosìdeo 3'-ou-2' substituìdos para tratamento de infecções por vìrus da hepatite
DE60105424D1 (de) Methoden zur behandlung von delta hepatitis virus infektionen mit beta-l-2' deoxy-nucleosiden
HUT61296A (en) Process for producing substituted diaromatic compounds against aids and pharmaceutical compositions comprising same
MD1507G2 (ro) Inhibitori, compoziţie farmaceutică pe baza lor şi procedeu de inhibare a HIV proteazei
AP1771A (en) 3'-Prodrugs of 2'-deoxy-?-L-nucleosides.
BR9815166A (pt) "método de inibição da replicação de vìrus, composto, método de inibição da replicação de citomegalovìrus, composto antiviral, utilização de um composto, composição farmacêutica, composição farmacêutica inibidora da replicação de vìrus e de citomegalovìrus e composição farmacêutica antiviral"
NO922949L (no) Forbindelser og fremgangsmaater for inhibering av hiv- og beslektede virus
AU3216695A (en) Lipid analogs for treating viral infections
DK0652005T3 (da) Fremgangsmåder til inhibering af endometriose
DK0771200T3 (da) Anvendelse af raloxifen og dets analoger til fremstilling af et medikament til behandling af virale sygdomme
FR2741619B1 (fr) Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
BR9502085A (pt) Derivado de 11,21-bis-fenil-19-norpregnano,processo de preparação do mesmo e composição farmaceutica
EA200000836A1 (ru) Применение n-замещенных 1,5-дидезокси-1,5-имино-d-глюцитных производных для лечения инфекций, вызываемых вирусами гепатита
DE69722004D1 (de) Nukleotidanaloga
NZ217398A (en) Angiotensin-converting enzyme(ace)inhibitor and pharmaceutical composition
ATE339211T1 (de) L-fmau zur behandlung von hepatitis-delta-virus- infizierung
CA2100066A1 (en) Michellamines useful as antiviral agents, composition and method of treatment
MD940152A (ro) Compoziţie farmaceutică pentru tratarea infecţiilor şi bolilor, provocate de virusul hepatitei V (HBV)
SE8302452D0 (sv) Method for treatment of senile dementia
FR2729665B1 (fr) Nouveaux derives de glycylanilides, leur preparation et leur application en therapeutique
DK0853619T3 (da) Disubstituerede piperidinderivater
WO1996013263A3 (en) Methods of treatment of viral disease with inhibitors of sphingolipid biosynthesis
FI944076A7 (fi) Menetelmä terapeuttisesti käytt¦kelpoisten N-(3-hydroksi-4-piperidinyyli)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentsodioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote